15 January 2016 - Hiberix is now indicated for the immunization of children aged six weeks through four years (prior to 5th birthday) against invasive disease caused by Haemophilus influenzae type b.

For more details, go to: https://us.gsk.com/en-us/media/press-releases/2016/fda-approves-expanded-use-of-gsk-hib-vaccine-from-booster-dose-to-full-series/